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In this study, 922 consecutive non-duplicate clinical isolates of Enterobacteriaceae obtained
from hospitalized and non-hospitalized patients at Bejaia, Algeria were analyzed for
AmpC-type -lactamases production. The ampC genes and their genetic environment
were characterized using polymerase chain reaction (PCR) and sequencing. Plasmid
incompatibility groups were determined by using PCR-based replicon typing. Phylogenetic
grouping and multilocus sequence typing were determined for molecular typing of the
plasmid-mediated AmpC (pAmpC) isolates.
Of the isolates, 15 (1.6%) were identiﬁed as AmpC producers including 14 CMY-4-
producing isolates and one DHA-1-producing Klebsiella pneumoniae.  All AmpC-producing
isolates co-expressed the broad-spectrum TEM-1 -lactamase and three of them co-
produced CTX-M and/or SHV-12 ESBL. Phylogenetic grouping and virulence genotyping of
the  E. coli isolates revealed that most of them belonged to groups D and B1. Multilocus
sequence typing analysis of K. pneumoniae isolates identiﬁed four different sequence types
(STs) with two new sequences: ST1617 and ST1618. Plasmid replicon typing indicates
that  blaCMY-4 gene was located on broad host range A/C plasmid, while LVPK replicon
was associated with blaDHA-1. All isolates carrying blaCMY-4 displayed the transposon-like
structures ISEcp1/ISEcp1-blaCMY-blc-sugE.Our study showed that 
Algeria.
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Introduction
Infection with resistant organisms is a major public
health issue. Enterobacteriaceae are important causes of both
community-acquired and healthcare-associated infections
in adults and children, and production of -lactamases is
of greater concern.1 Plasmid-mediated AmpC (pAmpC) -
lactamases have emerged and are being reported worldwide
with varying prevalence rates.2 They have been mainly
detected in Escherichia coli, Klebsiella spp., Salmonella spp.,
and Proteus mirabilis.3 These enzymes confer resistance
to penicillins, ﬁrst and third generation cephalosporins,
cephamycins, and monobactams such as aztreonam. They are
poorly inhibited by the commercially available -lactamase
inhibitors such as clavulanic acid, but are inhibited by
cloxacillin and phenylboronic acid. Treatment options are
severely limited because pAmpC are often associated with
other multiple resistance genes, such as those of resistance
to quinolones as well as other -lactamase genes.3,4 The
acquired ampC genes have emerged following mobilizations
mediated by such elements as IS26,  ISEcp1,  or ISCR1.3 Thus,
ISEcp1 has played an important role in mobilizing blaCMY-2-
like genes, since it is often found at their 5′ ﬂanks.5,6 It has
been identiﬁed in plasmids of the Inc A/C and Inc I1 groups.5–7
ISCR1 elements have been found adjacent to a number of
ampC genes, including blaDHA-1, as well as plasmid-mediated
quinolone resistance determinant qnr.8 Generally, the blaDHA-1
gene has been mainly associated with Inc FII and Inc L/M
plasmids.9
In Algeria, only few reports on plasmid-encoded AmpC
(CMY-2 and DHA-1) in Enterobacteriaceae strains recovered from
hospital settings were published.10–12
The aim of this study was to investigate the prevalence
and molecular epidemiology of cefoxitin resistance among
Enterobacteriaceae isolates recovered from hospitalized and
non-hospitalized patients in Bejaia locality (Algeria). The asso-
ciation of pAmpC with extended-spectrum -lactamase (ESBL)
and plasmid-mediated quinolone resistance determinant was
also studied.
Materials  and  methods
Bacterial  strains
A total of 922 non-duplicate isolates (one per patient) of Entero-
bacteriaceae were collected from March 2005 to April 2010 from
the Microbiology Laboratories of ﬁve hospitals and four private
laboratories in Bejaia (Algeria). The isolates were recovered
from various pathological specimens and were identiﬁed by
the API 20E system (bioMérieux, Marcy  l’Etoile, France) as fol-
lows: E. coli (n = 551); Klebsiella pneumoniae (n = 221); P. mirabilis
(n = 125) and Salmonella sp. (n = 25).
E. coli J53AzR was used as recipient strains for conjugation
experiments. E. coli DH10B (Invitrogen) was used in trans-
formation experiments and E. coli ATCC 25922 was used as
a quality control strain for antimicrobial susceptibility test-
ing. 1 5;1  9(2):187–195
Antimicrobial  susceptibility  testing
Antibiotic susceptibility was determined on Mueller Hinton
agar by standard disk diffusion procedure as described by the
European Committee on Antimicrobial Susceptibility Testing
(2014),13 for the following antibiotics: aztreonam, ticarcillin,
piperacillin, amoxicillin–clavulanate, ticarcillin–clavulanate,
cefoxitin, cefepime, piperacillin–tazobactam, cefuroxime,
cefotaxime, ceftazidime, imipenem, tobramycin, amikacin,
gentamicin, sulfonamide, trimethoprim, nalidixic acid,
ciproﬂoxacin, norﬂoxacin, tetracycline, and chlorampheni-
col (BioRad, Marnes La Coquette, France). For tetracycline,
the Antibiogram Committee of the French Society for
Microbiology recommendations breakpoints were used
(http://www.sfm-microbiologie.org).
Isolates showing a zone of inhibition diameter ≤20 mm
with cefoxitin were selected for screening for pampC genes.
ESBL production was detected by a double-disk synergy test
(DDST) on Mueller Hinton supplemented with cloxacillin
(200 mg/L).14 Inducibility of the -lactamase was deter-
mined by the double disk test. The cephalosporins used
were cefotaxime, ceftazidime, and cefepime. Clavulanic acid
(10 g) and cefoxitin (30 g) were used as inducing agents.
The plates were examined after overnight incubation at
37 ◦C.15
Minimum inhibitory concentrations (MICs) of amoxicillin,
amoxicillin/clavulanate, piperacillin/tazobactam, cefotaxime,
ceftazidime, cefoxitin, imipenem, aztreonam, and cefepime
were determined by Etest (AB bioMérieux, Marcy l’Etoile,
France).
Molecular  characterization  of  resistance  determinants
Total DNA was extracted by using a QIAmp DNA Mini Kit
(QIAGEN) according to the instructions of the manufacturer.
A multiplex PCR covering the six families of ampC genes
(CMY-2/BIL/LAT, CMY-1/MOX, DHA, FOX, ACC, ACT/MIR) was
performed as previously described.16 PCR-positive isolates
were further tested using individual pairs of primers and
then sequenced. pAmpC-producing isolates positive for the
DDST were screened for blaCTX-M, blaTEM and blaSHV by PCR as
described previously.17
Screening of qnrA, qnrB, qnrS, qnrC, qnrD and qepA genes
was carried out with a multiplex real-time PCR assay
using SYBR Green I and Roche LightCycler1 as described
previously.18 Pyrosequencing method was used for the detec-
tion of aac(6′)-Ib-cr and aac(6′)-Ib genes.19
All PCR products were sequenced and the sequencing
results were compared to reported sequences available in Gen-
Bank.
Transfer  of  resistance
Conjugation was performed on Mueller Hinton agar supple-
mented with sodium azide (100 mg/L) and cefotaxime (1 mg/L).
Transconjugants growing on the selection plates were sub-
jected to antimicrobials susceptibility, DDST and PCR analysis
to conﬁrm the presence of the AmpC phenotype.
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olecular  typing
ossible genomic relatedness of strains was analyzed by RAPD
sing genomic DNA as previously described.20 Multilocus
equence typing (MLST) was performed on the K. pneumo-
iae isolates using seven conserved housekeeping genes (gapA,
nfB, mdh, pgi, phoE, rpoB and tonB).21 A detailed protocol of
he MLST procedure, including allelic type and ST assignment
ethods, is available in MLST databases from the Pasteur
nstitute, Paris, France, at the website http://www.pasteur.fr/
echerche/genopole/PF8/mlst/Kpneumoniae.html.
hylogenetic  groups  and  virulence  genotyping  of  E.  coli
CRs were performed to determine the phylogenetic groups
A, B1, B2, C, D, E, F, and clade I) of the E. coli isolates, using
he newly  revised Clermont method.22 All isolates belonging
o group B2 were analyzed by two multiplex PCR as described
reviously.23 The presence of eight virulence factors found
n ExPEC was investigated by PCR. These factors included
fa/foc (S and F1C ﬁmbriae), papG alleles (G adhesin classes
f P ﬁmbriae), papC (C adhesin classes of P ﬁmbriae), hlyA
alpha-haemolysin A), cnf (cytotoxic necrotizating factor 1),
yuA (genes of yersiniabactin), iutA (aerobactin receptor), and
beA (invasion protein IbeA).
lasmid  replicon  typing
lasmids incompatibility (Inc) groups were determined using
CR-based replicon typing (PBRT).24 Four multiplex PCR were
sed for the detection of A/C, T, FIIAs, W,  N, FIB, L/M, I1-I, X,
I2, FIA, and Y replicons. Replicons P, R, U, F, FIC, HI1, B/O and
 were detected by simplex PCR.24,25 Replicons FII1K, FII2K,
ewXXX also named ZK, LVPK, and Amet were detected using
CR method described by D. Decré and G. Arlet.
enetic  organization  of  blaampC genes
or the analysis of genetic arrangement of the resistance
enes, overlapping PCR ampliﬁcation of internal regions of the
ransposon-like element that carried blaCMY-4 was performed
ased on known sequences.
Genetic structures surrounding the blaDHA-1 gene were
tudied by PCR mapping, cloning and sequencing method
sing a large variety of primers based on the previously
eported structures.8
The nucleotide sequence and the deduced protein
equence were analyzed using the Basic Local Alignment
earch Tool (BLAST) through the Internet (http://www.ncbi.
lm.nih.gov/BLAST/). Multiple sequence alignment of
educed peptide sequences was carried out with the Vector
TI program (Invitrogen).
esultsacterial  isolates  and  antibiotic  susceptibility
mong the 922 Enterobacteriaceae isolates, 15 isolates showed
ecreased susceptibility to cefoxitin: nine isolates of E. coli5;1 9(2):187–195 189
(9/551), ﬁve isolates (5/221) of K. pneumoniae and one isolate
(1/125) of P. mirabilis. Ten isolates were recovered from urine.
Six E. coli isolates and one K. pneumoniae isolate were from com-
munity patients (7/712), and the remaining eight isolates were
collected from hospitalized patients (8/210).
All isolates exhibited resistance to ticarcillin, piperacillin,
ticarcillin–clavulanic acid, amoxicillin–clavulanic acid,
cefuroxime, cefotaxime, ceftazidime, aztreonam, and
cefoxitin. Isolates exhibited intermediate resistance to
piperacillin–tazobactam (60%) and cefepime (40%). Resistance
of the isolates to non--lactam antibiotics was high for
sulfonamide (80%), tobramycin (71.4%), gentamicin (71.4%),
tetracycline (71.4%), chloramphenicol (64.3%) and trimetho-
prim (57.1%), and low for nalidixic acid (28.6%) and amikacin
(6.6%). The isolates remain susceptible to imipenem and
ﬂuoroquinolones. The MICs ranges are listed in Table 1.
The ESBL phenotypic screening by double disk diffusion
synergy test showed that one isolate of K. pneumoniae and two
isolates of E. coli were ESBL producers (Table 1).
Inducibility of -lactamases was recognized by the
disk antagonism test, which demonstrated blunting of the
cephalosporin disks adjacent to the cefoxitin and clavulanic
acid disks in only one isolate of K. pneumoniae 413. This phe-
notype suggested the presence of an inducible AmpC-type
-lactamase.
Genotypic  analysis  of  antibiotic  resistance  genes
By multiplex PCR, we  obtained amplicons in 15 isolates: nine
E. coli isolates, ﬁve K. pneumoniae isolates, and one P. mirabilis
isolate (Table 1).
PCR and sequencing analysis revealed the presence of
blaCMY-4 in all isolates except one isolate of K. pneumonia,  which
produced blaDHA-1.
In addition, two E. coli (CMY-4) co-produced CTX-M-15
ESBLs and one isolate of K. pneumoniae (DHA-1) co-produced
CTX-M-3 and SHV-12 ESBL. All isolates carried blaTEM-1.
PCR ampliﬁcation of PMQR yielded ampliﬁcation in one K.
pneumoniae isolate only. This strain expressed both the qnrB4,
aac(6′)-Ib, blaDHA-1, blaCTX-M-3, blaSHV-12 and blaTEM-1 genes
(Table 1).
No amplicons were obtained for qnrA, qnrS, qnrD, qnrC and
qepA in all isolates.
Conjugation  and  replicon  typing
By mating assay, the ampC genes were transferred from three
of the ﬁve K. pneumoniae, ﬁve of the nine E. coli isolates and from
the P. mirabilis isolate. Susceptibility results of the transconju-
gants are shown in Table 1.
PBRT of the plasmid Inc groups showed that the plasmids
carrying blaCMY-4 belonged to the Inc A/C group and the plas-
mid  carrying blaDHA-1 belonged to the group Inc LVPK (Table 1).
Molecular  typingRAPD-typing revealed the presence of diverse bacterial pop-
ulation and no predominant clone was identiﬁed in our
collection.
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Table 1 – Microbiological features of pAmpC producing Enterobacteriaceae.
Isolates and
transconjugants
Date of
isolation
Specimen Hospital/
private
labora-
tory
Ward Plasmid-
mediated
blaAmpC
Other
-lactamases
genes
PMQRs
genes
MICs  (mg/L) RAPD
clone
MLST (K.
pneumoniae)
Replicon
typing
AMX AMC TZP CTX CAZ ATM FEP IMP FOX
K. pneumoniae 47 04/04/2007 Urine AWH Surgery CMY-4 TEM-1 – >256 48 >256 >32 >256 32 <04 0.38 64 K.A. 17 Inc A/C,
LVPK
TC47 CMY-4 – >256 16 128 >32 128 32 <04 0.19 32 Inc A/C
K. pneumoniae 123 04/05/2005 Urine AWH Pediatrics CMY-4 TEM-1 – >256 32 >256 >32 >256 32 >64 0.38 64 K.B. 1617 Inc A/C,
FIB, F, P
TC123 CMY-4 – >256 16 16 12 12 <04 <04 0.25 32 Inc A/C
K. pneumoniae 613 05/04/2010 Feces AZH Medicine CMY-4 – >256 16 08 >32 192 32 <04 0.25 64 K.D. 1618 ND
K. pneumoniae 615 03/05/2010 Feces AZH Medicine CMY-4 – >256 16 08 >32 192 32 <04 0.25 64 K.D. 1618 ND
K. pneumoniae 413 21/04/2008 Feces AZH Surgery DHA-1 TEM-1;
CTX-M-3;
SHV-12
QnrB4 >256 16 02 >32 48 32 16 0.19 16 K.C. 834 Inc L/M,
LVPK, HI2
TC413 DHA-1 TEM-1 QnrB4,
acc(6)-Ib
>256 02 0.38 0.19 03 <04 <04 0.032 16 Inc LVPK
E. coli 234 15/04/2007 Urine AZH Surgery CMY-4 TEM-1;
CTX-M-15
– >256 32 >256 >32 >256 32 >64 0.5 64 E.A. Inc A/C, F,
P, FII2K
TC234 CMY-4 – >256 16 12 >32 96 32 <04 0.25 64 Inc A/C
E. coli 412 22/04/2008 Feces AZH Pediatrics CMY-4 TEM-1 – >256 32 >256 >32 >256 32 <04 0.5 32 E.B. Inc A/C,
FIA, A/C,
FIB, F, B/O,
U
TC412 CMY-4 – >256 16 >256 >32 48 32 <04 0.25 32 Inc A/C,
E. coli 535 14/04/2009 Urine LPL Community CMY-4 TEM-1 – >256 16 16 >32 >256 32 <04 0.25 64 E.C. Inc A/C,
FIB, HI1
E. coli 538 14/02/2009 Urine LPL Community CMY-4 TEM-1 – >256 16 08 >32 128 32 <04 0.19 64 E.D.  Inc A/C,
FIB, FIA,
FII 1K, U
TC538 LPL CMY-4 – >256 16 04 >32 64 32 <04 0.19 32 Inc A/C
E. coli 539 05/04/2009 Urine LPL Community CMY-4 TEM-1 – >256 16 16 >32 >256 32 <04 0.25 64 E.C. Inc A/C,
FIB, HI1
E. coli 545 24/02/2009 Urine LPL Community CMY-4 TEM-1 – >256 16 08 >32 128 32 <04 0.19 64 E.D.  Inc A/C,
FIB, FIA,
FII 1K, U
E. coli 560 01/12/2009 Urine LPL Community CMY-4 TEM-1 – >256 16 08 >32 128 32 <04 0.19 64 E.D.  Inc A/C,
FIB, FIA,
FII 1K, U
E. coli 606 21/04/2010 Urine DPL Community CMY-4 TEM-1 – >256 16 04 >32 48 08 <04 0.19 32 E.E. ND
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E. coli 611 28/05/2010 Feces AZH Surgery CMY-4 TEM-1,
CTX-M-15
– >256 16 04 >32 64 32 16 0.25 64 E.F. Inc FIA, I1,
F, U, FII 1K
TC611 CMY-4 – >256 16 02 >32 08 32 <04 0.25 32 Inc A/C
P. mirabilis 128 07/04/2005 Urine AZH Surgery CMY-4 TEM-1 – >256 48 12 >32 48 <04 <04 0.25 32 – Inc A/C
TC128 CMY-4 – >256 16 0.75 >32 24 <04 <04 0.25 32 Inc A/C
LPL, Lalaoui private laboratory; DPL, Djama private laboratory; AZH, Amizour hospital; AWH, Amriw hospital; TZP, piepracillin–tazobactam; AMX, amoxicillin; AMC, amoxicillin–clavulanic acid; FOX,
cefoxitin; ATM, aztreonam; CTX, cefotaxime; CAZ, ceftazidime; FEP, cefepime; IMP, imipenem; ND, not determined.
i s . 2 0192  b r a z j i n f e c t d 
MLST analysis of the ﬁve AmpC-producing K. pneumoniae
identiﬁed four different STs, including ST17, ST834 and two
new sequence types: ST1617 (Kp 123) and ST1618 (Kp 613 and
615) (Table 1). In ST1618, we described a new allele’s mdh and
rpoB designated respectively 145 and 108. The typing results
generated by RAPD analysis among the isolates were compat-
ible with those obtained by MLST.
E.  coli  phylogenetic  groups  and  virulence  factors
Of the nine E. coli isolates, three belonged to group D, three to
group B1 (recovered from urine), two to group B2, and the last
one to group F (Table 2).
Five isolates harbored genes encoding siderophores (fyuA,
iutA).
The E. coli 412 isolate was assigned to the B2 sub-group VII
and STc14. This strain was isolated from the feces of a hos-
pitalized patient. This isolate contained a blaTEM-1 gene and,
a blaCMY-4 gene, which was transferred with an Inc A/C plas-
mid. The following virulence genes (papC, papG II, sfa,  hlyA,
cnf1, fyuA and iutA) were detected in this isolate (Table 2).
By using allele-speciﬁc PCR method for detecting the main
E. coli B2 STc, E. coli 611 isolate was unassigned; it did not give
any PCR products except for the internal control.
Characterization  of  the  genetic  contexts  of  blaAmpC genes
Analysis of the genetic structure of the blaCMY-4 gene in our
collection showed that it was located on a transposon-like
DNA element consisting of a speciﬁc ISEcp1/ISEcp1-blaCMY-4-
blc-sugE structure. This structure was similar to that found in
plasmid pCC416 (GenBank AJ875405).
A region typical of a complex sul1-type integron, from the
int gene to CR1 was ampliﬁed using PCR mapping and then
sequenced. By cloning the region encompassing ampC and
ampR, a recombinant plasmid (p413C) with an insert that con-
ferred inducible resistance to ceftazidime was selected. The
insert was found to contain blaDHA-1 and the regulatory gene
ampR, which was downstream of blaDHA-1. This insert shared
also part of pRBDHA’s backbone carrying a complex integron
(GenBank AJ971343). PCR and DNA sequencing results con-
ﬁrmed that the plasmid encoded at least three -lactamase
Table 2 – Distribution and combination patterns of virulence ge
pAmpC-producing E. coli.
Strain Adhesin Toxin 
papC papG II sfa hlyA cnf1 
234 − − − − − 
412 + + + + + 
535 − − − − − 
538 − − − − − 
539 − − − − − 
545 − − − − − 
560 − − − − − 
606 − − − − − 
611 − − − − − 
Groups F and B1 were not found in any selected virulence genes. 1 5;1  9(2):187–195
genes: blaTEM-1, blaSHV-12, and blaDHA-1, and a plasmid medi-
ated resistance to quinolone (QnrB4).
Discussion
pAmpC have been found worldwide but are less common than
ESBLs.3 They are emerging worldwide in various species of
Enterobacteriaceae as a mechanism of acquired resistance to
cefoxitin. In our study 1.6% (n = 15) of the screened Entero-
bacteriaceae isolates were cefoxitin-resistant and produced
plasmid-mediated AmpC -lactamases. Prevalence of pAmpC
in Algeria is not known, due to the limited number of
epidemiological surveys. In Algeria, Iabaden et al. reported
a prevalence of plasmid mediated AmpC -lactamases of
2.18%.11 Mata et al. reported a signiﬁcant increase in over-
all prevalence of Enterobacteriaceae carrying acquired AmpC
in a Spanish hospital which was 0.43%, rising from 0.06%
(1999) to 1.3% (2007).26 A prevalence of 12.5% was reported by
Mohamudha et al. in India.27
Our study demonstrated that pAmpC-producing Enterobac-
teriaceae might be the cause of nosocomial and community
infections in Algeria. Of note, we  found that 40% of the
cases were recovered from non-hospitalized patients. Isola-
tion of pAmpC-producing Enterobacteriaceae from community
was reported by many  authors.28,29 Nursing homes and
community-based sources of pAmpC-producers can pose a
serious risk of transmission to hospitalized patients when
infected or colonized patients are admitted. Gude et al. have
found this resistance mechanism on isolates from commu-
nity patients in a high rate, underscoring the need for close
surveillance of these isolates.30 Several studies reported the
isolation of pAmpC-producing Enterobacteriaceae isolates from
food products, such as retail chicken meat, retail meat, and
cheese.31–33 Thus, food chain might be a relevant vehicle for
transmission of these enzymes in the community. They have
also been detected in drinking water and river beaches.34
These sources could contribute to the spread of global pAmpC-
producers in addition to a possible transmission of mobile
30genetic elements carrying resistance genes among strains.
In Algeria, CMY-2 and DHA-1 were previously reported by
Messai et al. (2006)10, Iabadene et al. (2009)11 and Nedjai et al.
(2012).12 This is the ﬁrst isolation of CMY-4  in clinical isolates
nes and phylogenetic groups detected in
Iron system Invasin Phylogenetic group
fyuA iutA ibeA
− − − F
+ + − B2
+ + − D
− − − B1
+ + − D
− − − B1
− − − B1
+ + − D
+ + − B2
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nosocomial and community infections) in Algeria. Thus, the
rst strain (K. pneumoniae 123) was isolated in 2005 from a
atient hospitalized at Bejaia hospital (Algeria). The predomi-
ance of CMY-4  was consistent with worldwide observations.
HA-1 has been mostly reported in Asia.5,35
In our study, E. coli isolates were mainly groups B2 and
 strains which are commonly extra-intestinal pathogenic
trains, while phylogenetic groups A and B1 strains, usu-
lly commensal, were less frequent.36 CMY-2  production was
eported in phylogenetic group D E. coli in humans and stray
ogs.5,37
In the study of Mnif et al., the non-ST131-group B2 isolates,
hich were associated to CTX-M-15 ESBLs, had a higher fre-
uency of several genes encoding key virulence factors such
s adhesins hra, sfa/foc,  papC and papG II, and the toxins hylA
nd cnf1 than had the ST131 isolates.38 In our study, a single
solate harbored several virulence genes iutA, papC and sfa/foc
nd belonged to phylogenetic group B2.
Our results showed that AmpC-producing K. pneumoniae
solates belonged to different sequence types. ST17 has been
reviously found in Cadiz, associated with CTX-M-15, in
reiburg and in Seoul, in Barcelona, associated with DHA-
.21,39–41 ST17 belongs to the ST17 complex, which contains
our single-locus variants and six double-locus variants.41 K.
neumoniae ST834 strains were previously involved in blaKPC
issemination in New Jersey.42 Besides the low number of iso-
ates, we have detected two news  sequences types: ST1617 and
T1618.
In this study, all isolates producing blaCMY-4 and blaDHA-1
o-expressed the broad-spectrum TEM-1 -lactamase and
hree of them co-produced CTX-M and/or SHV ESBL. This
nzyme combination complicates their detection and treat-
ent. blaCMY-4 gene was located on broad host range A/C
onjugative plasmid which was among the most commonly
eported worldwide. In the last decades, Inc A/C plasmids
ave been associated with the spread of the AmpC beta
actamase CMY-2, in strains isolated from human, beef,
hicken, turkey, and pork, revealing that this common plasmid
ackbone is broadly disseminated among resistant zoonotic
athogens.9,43
In our study, the genetic organization of blaCMY-4 and
ts variants was highly conserved. All the isolates carried
he transposon-like element ISEcp1 (ISEcp1/ISEcp1-blaCMY-
lc-sugE), as documented previously.44
The blaDHA-1gene was previously found on different plas-
ids of Inc groups A/C, FIA, FII, L/M, N, R and HI2 or of
nknown Inc groups.9,11,26,41,45 Nevertheless, it is worth noting
hat blaDHA-1 gene was located on LVPK conjugative plas-
id. Linkage of blaDHA-1 and qnrB4 genes of similar structures
as been described in isolates of K. pneumoniae.8 The asso-
iation among blaDHA-1, qnrB4, and aac(6′)-Ib-cr was reported
efore.46 The K. pneumoniae 413 strain in our study harbored a
ombination of -lactamase genes (blaCTX-3, blaDHA-1, blaSHV-12
nd blaTEM-1), PMQR determinants (qnrB4 gene) and amino-
lycoside acetyltransferase gene (aac(6′)-Ib). Despite several
nvestigations, we  could not determine the origin of this
ultiresistant strain. To our knowledge, this is the ﬁrst
escription of this association of genes including blaCTX-M-3 in
he same strain. Identiﬁcation of the sequences surrounding
he blaDHA-1 gene found an ampR gene included in a complex
15;1 9(2):187–195 193
sul-1-type integron that was likely similar to those previously
reported.8
Use of antibiotics in both humans and animals, the global
mobility of populations, and food products perpetuate the
spread of multiresistant bacterial clones and resistance genes.
Early identiﬁcation of these organisms is necessary as the
appropriate treatment might reduce the spread of these
resistant strains and consequently mortality of hospitalized
patients can be reduced. This emphasizes the need for such
enzymes detection for preventing this emerging resistance
into hospitals and for controlling its spread within the com-
munity. That will avoid therapeutic failures and nosocomial
outbreaks.
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